CUV 0.00% $14.50 clinuvel pharmaceuticals limited

wallstreet reporter, page-6

  1. 14,434 Posts.
    lightbulb Created with Sketch. 609
    I heard the report as well if phase 11 trials are a success in 3-4 weeks the stock will be re-valued. This stock is the next chemeq
 
watchlist Created with Sketch. Add CUV (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.